Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alcohol SCHEMBL28244818 | 1.00 | — | — | |
| Tetrahydrothiophene SCHEMBL8372033 | 0.97 | — | — | |
| Alcohol SCHEMBL11313867 | 0.89 | — | — | |
| SCHEMBL27535648 | 0.86 | — | — | |
| Tetrahydrothiophene SCHEMBL5712295 | 0.79 | — | — | |
| Alcohol SCHEMBL28625593 | 0.78 | — | — | |
| Ethane SCHEMBL28147637 | 0.78 | — | — | |
| Tetrahydrothiophene SCHEMBL10967860 | 0.78 | — | — | |
| Cyclohexane SCHEMBL959934 | 0.78 | — | — | |
| Cyclohexane SCHEMBL9633835 | 0.78 | ALDH1A1 (0.67) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015260-A1 | Synthesis of synthons for the manufacture of bioactive compounds | DIVERSA CORPORATION | 2007-01-18 | — | — | US | disclosed |
| EP-1485498-A4 | SYNTHESIS OF SYNTHONS FOR THE MANUFACTURE OF BIOACTIVE COMPOUNDS | SCRIPPS RESEARCH INST (US) | 2006-09-13 | — | — | EP | disclosed |
| EP-1485498-A2 | SYNTHESIS OF SYNTHONS FOR THE MANUFACTURE OF BIOACTIVE COMPOUNDS | The Scripps Research Institute (US) | 2004-12-15 | — | — | EP | disclosed |
| US-20030232416-A1 | Synthesis of synthons for the manufacture of bioactive compounds | SCRIPPS RESEASRCH INSTITUTE, THE | 2003-12-18 | — | — | US | disclosed |
| WO-2003077868-A2 | SYNTHESIS OF SYNTHONS FOR THE MANUFACTURE OF BIOACTIVE COMPOUNDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2003-09-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232416-A1 | Synthesis of synthons for the manufacture of bioactive compounds | DERA, ALDOA, DPYD | ALDH1A1 34/4885TSHR 4735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.